13F HOLDINGS REPORT
Lynx1 Capital Management LP
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001910456-26-000001
Total Value
$494.0M
Positions
22
Other Managers
1
Confidential Omitted
No
Holdings (22)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | STOKE THERAPEUTICS INC | STOK | 5,404,674 | $171.5M | 34.73% |
| 2 | GH RESEARCH PLC | GHRS | 10,406,575 | $132.2M | 26.75% |
| 3 | CULLINAN THERAPEUTICS INC | CGEM | 8,963,500 | $92.8M | 18.78% |
| 4 | DENALI THERAPEUTICS INC | DNLI | 1,738,750 | $28.7M | 5.81% |
| 5 | C4 THERAPEUTICS INC | CCCC | 7,098,133 | $13.6M | 2.74% |
| 6 | XENCOR INC | XNCR | 705,558 | $10.8M | 2.19% |
| 7 | IMMATICS N.V | IMTX | 921,950 | $9.7M | 1.96% |
| 8 | TSCAN THERAPEUTICS INC | TCRX | 8,019,148 | $8.0M | 1.62% |
| 9 | PASSAGE BIO INC | PASG | 623,704 | $7.4M | 1.49% |
| 10 | KORRO BIO INC | KRRO | 677,915 | $5.4M | 1.10% |
| 11 | PRECISION BIOSCIENCES INC | DTIL | 993,913 | $4.1M | 0.84% |
| 12 | NEUPHORIA THERAPEUTICS INC | NEUP | 875,228 | $3.4M | 0.69% |
| 13 | AGIOS PHARMACEUTICALS INC | AGIO | 79,624 | $2.2M | 0.44% |
| 14 | CG ONCOLOGY INC | CGON | 31,591 | $1.3M | 0.27% |
| 15 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 12,043 | $799,535 | 0.16% |
| 16 | DESIGN THERAPEUTICS INC | DSGN | 69,516 | $652,060 | 0.13% |
| 17 | ENTRADA THERAPEUTICS INC | TRDA | 51,689 | $531,363 | 0.11% |
| 18 | WEREWOLF THERAPEUTICS INC | HOWL | 655,926 | $415,529 | 0.08% |
| 19 | MAPLIGHT THERAPEUTICS INC | MPLT | 13,477 | $236,724 | 0.05% |
| 20 | GENERATION BIO CO | 37148K209 | 25,000 | $142,000 | 0.03% |
| 21 | PROQR THRAPEUTICS N V | N71542109 | 68,486 | $138,342 | 0.03% |
| 22 | APPLIED THERAPEUTICS INC | 03828A101 | 410,500 | $41,050 | 0.01% |